The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning

Overview

Journal Neuropsychopharmacology

Date 2017 Apr 21

PMID 28425495

Citations 15

Authors

Erin N Bobeck

Ivone Gomes

Darlene Pena

Kirstie A Cummings

Roger L Clem

Mihaly Mezei

Lakshmi A Devi

Affiliations

Soon will be listed here.

Abstract

Studies show that neuropeptide-receptor systems in the basolateral amygdala (BLA) play an important role in the pathology of anxiety and other mood disorders. Since GPR171, a recently deorphanized receptor for the abundant neuropeptide BigLEN, is expressed in the BLA, we investigated its role in fear and anxiety-like behaviors. To carry out these studies we identified small molecule ligands using a homology model of GPR171 to virtually screen a library of compounds. One of the hits, MS0021570_1, was identified as a GPR171 antagonist based on its ability to block (i) BigLEN-mediated activation of GPR171 in heterologous cells, (ii) BigLEN-mediated hyperpolarization of BLA pyramidal neurons, and (iii) feeding induced by DREADD-mediated activation of BigLEN containing AgRP neurons in the arcuate nucleus. The role of GPR171 in anxiety-like behavior or fear conditioning was evaluated following systemic or intra-BLA administration of MS0021570_1, as well as following lentiviral-mediated knockdown of GPR171 in the BLA. We find that systemic administration of MS0021570_1 attenuates anxiety-like behavior while intra-BLA administration or knockdown of GPR171 in the BLA reduces anxiety-like behavior and fear conditioning. These results indicate that the BigLEN-GPR171 system plays an important role in these behaviors and could be a novel target to develop therapeutics to treat psychiatric disorders.

Citing Articles

The role of orphan G protein-coupled receptors in pain.

Xu C, Wang Y, Ni H, Yao M, Cheng L, Lin X Heliyon. 2024; 10(7):e28818.

PMID: 38590871 PMC: 11000026. DOI: 10.1016/j.heliyon.2024.e28818.

Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis.

Yin G, Zheng S, Zhang W, Dong X, Qi L, Li Y Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(1):47-57.

PMID: 38229504 PMC: 10945491. DOI: 10.3724/zdxbyxb-2023-0343.

A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.

Kawasoe K, Watanabe T, Yoshida-Sakai N, Yamamoto Y, Kurahashi Y, Kidoguchi K Cancers (Basel). 2023; 15(20).

PMID: 37894456 PMC: 10605931. DOI: 10.3390/cancers15205089.

Reduced urine volume and changed renal sphingolipid metabolism in P2ry14-deficient mice.

Baalmann F, Brendler J, Butthof A, Popkova Y, Engel K, Schiller J Front Cell Dev Biol. 2023; 11:1128456.

PMID: 37250906 PMC: 10213973. DOI: 10.3389/fcell.2023.1128456.

A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice.

McDermott M, Ram A, Mattoon M, Haderlie E, Raddatz M, Thomason M Pharmacol Biochem Behav. 2023; 224:173543.

PMID: 36933620 PMC: 11472835. DOI: 10.1016/j.pbb.2023.173543.

References

Kakarala K, Jamil K . Sequence-structure based phylogeny of GPCR Class A Rhodopsin receptors. Mol Phylogenet Evol. 2014; 74:66-96. DOI: 10.1016/j.ympev.2014.01.022. View

Christiansen S, Olesen M, Gotzsche C, Woldbye D . Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice. Neuropeptides. 2014; 48(6):335-44. DOI: 10.1016/j.npep.2014.09.004. View

Lein E, Hawrylycz M, Ao N, Ayres M, Bensinger A, Bernard A . Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2006; 445(7124):168-76. DOI: 10.1038/nature05453. View

Stamatakis A, Sparta D, Jennings J, McElligott Z, Decot H, Stuber G . Amygdala and bed nucleus of the stria terminalis circuitry: Implications for addiction-related behaviors. Neuropharmacology. 2013; 76 Pt B:320-8. PMC: 3858407. DOI: 10.1016/j.neuropharm.2013.05.046. View

Cipriano A, Gomes K, Nunes-de-Souza R . CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze. Horm Behav. 2016; 81:59-67. DOI: 10.1016/j.yhbeh.2016.03.002. View

Smith Y, Pare D . Intra-amygdaloid projections of the lateral nucleus in the cat: PHA-L anterograde labeling combined with postembedding GABA and glutamate immunocytochemistry. J Comp Neurol. 1994; 342(2):232-48. DOI: 10.1002/cne.903420207. View

Piccoli G, Onofri F, Cirnaru M, Kaiser C, Jagtap P, Kastenmuller A . Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain. Mol Cell Biol. 2014; 34(12):2147-61. PMC: 4054300. DOI: 10.1128/MCB.00914-13. View

Gomes I, Aryal D, Wardman J, Gupta A, Gagnidze K, Rodriguiz R . GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proc Natl Acad Sci U S A. 2013; 110(40):16211-6. PMC: 3791715. DOI: 10.1073/pnas.1312938110. View

McDonald A, AUGUSTINE J . Localization of GABA-like immunoreactivity in the monkey amygdala. Neuroscience. 1993; 52(2):281-94. DOI: 10.1016/0306-4522(93)90156-a. View

10.

Rozenfeld R, Gupta A, Gagnidze K, Lim M, Gomes I, Lee-Ramos D . AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. EMBO J. 2011; 30(12):2350-63. PMC: 3116274. DOI: 10.1038/emboj.2011.139. View

11.

Silberman Y, Ariwodola O, Chappell A, Yorgason J, Weiner J . Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation. Neuropsychopharmacology. 2010; 35(9):1886-96. PMC: 3055643. DOI: 10.1038/npp.2010.59. View

12.

Hodes G, Pfau M, Purushothaman I, Ahn H, Golden S, Christoffel D . Sex Differences in Nucleus Accumbens Transcriptome Profiles Associated with Susceptibility versus Resilience to Subchronic Variable Stress. J Neurosci. 2015; 35(50):16362-76. PMC: 4679819. DOI: 10.1523/JNEUROSCI.1392-15.2015. View

13.

Wardman J, Gomes I, Bobeck E, Stockert J, Kapoor A, Bisignano P . Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake. Sci Signal. 2016; 9(430):ra55. PMC: 5150984. DOI: 10.1126/scisignal.aac8035. View

14.

Carlsen J . Immunocytochemical localization of glutamate decarboxylase in the rat basolateral amygdaloid nucleus, with special reference to GABAergic innervation of amygdalostriatal projection neurons. J Comp Neurol. 1988; 273(4):513-26. DOI: 10.1002/cne.902730407. View

15.

Silberberg D, Anand N, Michels K, Kalaria R . Brain and other nervous system disorders across the lifespan - global challenges and opportunities. Nature. 2015; 527(7578):S151-4. DOI: 10.1038/nature16028. View

16.

Desai S, Upadhya M, Subhedar N, Kokare D . NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell. Behav Brain Res. 2013; 247:79-91. DOI: 10.1016/j.bbr.2013.03.018. View

17.

Anighoro A, Graziani D, Bettinelli I, Cilia A, De Toma C, Longhi M . Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity. Bioorg Med Chem. 2015; 23(13):3040-58. DOI: 10.1016/j.bmc.2015.05.008. View

18.

Sajdyk T, Johnson P, Leitermann R, Fitz S, Dietrich A, Morin M . Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci. 2008; 28(4):893-903. PMC: 6671007. DOI: 10.1523/JNEUROSCI.0659-07.2008. View

19.

Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E . Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal. 2010; 3(131):ra54. PMC: 3125674. DOI: 10.1126/scisignal.2000807. View

20.

Cavasotto C, Orry A, Murgolo N, Czarniecki M, Kocsi S, Hawes B . Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J Med Chem. 2008; 51(3):581-8. DOI: 10.1021/jm070759m. View